Sirdupla (fluticasone propionate salmeterol xinafoate): Reviews and patient testimonials
Back to the list of medications
Medication indications
Sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension
Sirdupla is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled glucocorticosteroid) is appropriate:
- patients not adequately controlled with inhaled glucocorticosteroids and 'as needed' inhaled short-acting β2 agonist or
- patients already adequately controlled on both inhaled glucocorticosteroid and long-acting β2 agonist
Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension
Sirdupla is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate:
- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting β2 agonist or
- patients already adequately controlled on both inhaled corticosteroid and long-acting β2 agonist
Route of administration: opinion.traitement.inhalation
Molecule: fluticasone propionate, salmeterol xinafoate
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.